Roivant Sciences (ROIV) EBITDA Margin Growth (1y) (2021 - 2025)
Roivant Sciences (ROIV) EBITDA Margin Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.29 Mn |
| Sep 30, 2025 | -1.19 Mn |
| Jun 30, 2025 | -1.19 Mn |
| Dec 31, 2024 | -2.50 Mn |
| Sep 30, 2024 | -177,280.00 |
| Jun 30, 2024 | -127.00 |
| Dec 31, 2023 | 2.44 Mn |
| Sep 30, 2023 | -362,303.00 |
| Jun 30, 2023 | 525,817.00 |
| Dec 31, 2022 | -42,081.00 |
| Sep 30, 2022 | 265,311.00 |
| Jun 30, 2022 | -454,049.00 |
| Dec 31, 2021 | 215,045.00 |
| Sep 30, 2021 | 693,895.00 |
| Jun 30, 2021 | 526,629.00 |